# Effect of L-dopa In Subacute Back Pain Population

> **NCT01951105** · PHASE4 · COMPLETED · sponsor: **Northwestern University** · enrollment: 72 (actual)

## Conditions studied

- Sub-acute Back Pain

## Interventions

- **DRUG:** Naproxen
- **DRUG:** Carbidopa/Levodopa
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01951105
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-24
- **Primary completion:** 2017-09-25
- **Final completion:** 2017-09-25
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2021-03-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01951105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01951105, "Effect of L-dopa In Subacute Back Pain Population". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01951105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*